performance with skills to be able to influence the health sector and demonstrate that it has count health policy outcomes done so? demonstrate a clear results focus Does DFAT have the capacity and expertise to • • backed by high calibre M&E deliver the investment? systems Are the proposed interventions recognised to be • work with partners who have the cost-effective? Do they invest in • ‘best-buys’? capacity to deliver, measure and Do the investments have a strong monitoring • be accountable for results and evaluation framework in place, or planned, generate the evidence to improve with appropriate indicators, baseline data and • multilateral/bilateral effectiveness targets? for health Can opportunities be taken to support national • support sharper program focus health information systems? E.g. disease data, • and consolidation surveillance, civil registration and vital statistics. Do partner organisations have the capacity to • report against monitoring and evaluation frameworks? Does DFAT have the means to harvest and • share the lessons of the investment for future practice? Does the investment contribute to consolidation • or fragmentation of portfolio? DFAT’s Annex 2: Global and multilateral organisations – comparative advantages in health
performance count with skills to be able to influence health policy outcomes • demonstrate a clear results focus backed by high calibre M&E systems • work with partners who have the capacity to deliver, measure and be accountable for results • generate the evidence to improve multilateral/bilateral effectiveness for health • support sharper program focus and consolidation the health sector and demonstrate that it has done so? • Does DFAT have the capacity and expertise to deliver the investment? • Are the proposed interventions recognised to be cost-effective? Do they invest in ‘best-buys’? • Do the investments have a strong monitoring and evaluation framework in place, or planned, with appropriate indicators, baseline data and targets? • Can opportunities be taken to support national health information systems? E.g. disease data, surveillance, civil registration and vital statistics. • Do partner organisations have the capacity to report against monitoring and evaluation frameworks? • Does DFAT have the means to harvest and share the lessons of the investment for future practice? • Does the investment contribute to consolidation or fragmentation of DFAT’s portfolio? Annex 2: Global and multilateral organisations – comparative advantages in health